Boster Bio Launches Free Antibody Validation Service to Transform Research Reproducibility
In a bold move that could reshape the future of biomedical research, Boster Bio is launching a Free Antibody Validation Program —giving scientists the power to test antibodies under their exact experimental conditions before purchase. It's a first-of-its-kind, no-cost service that tackles one of science's most frustrating pain points: unreliable antibodies.
'For too long, researchers have had to gamble on antibodies that may or may not work,' said CJ Xia, Founder and VP of Boster Bio. 'We believe that's unacceptable. Our free validation service gives you proof before you pay—so your research runs smoother, faster, and with far fewer surprises.'
Why It Matters
Antibodies are the backbone of modern life sciences. Yet according to studies, over 50% of research antibodies are poorly validated, leading to inconsistent results, failed experiments, and wasted budgets.
Boster Bio's solution? A fast, AI-assisted validation pipeline that tests antibodies for specificity and performance using over 500 in-house tissue and lysate types across applications like Western blot (WB), IHC, IF, ELISA, FC, and IP—all tailored to the researcher's exact assay needs.
How It Works:
Submit in 2 Minutes: Fill out a quick online form or reply by email with your biomarker list, sample types, and applications.
We Test for You: Our team validates your requested antibodies in-house—no samples or reagents needed from your lab.
Fast Turnaround: You'll receive a full validation report, including protocols and results, in 4–10 days.
Built for Today's Research Environment
With time and funding tighter than ever, researchers deserve tools that help them focus on publishing, not troubleshooting. Boster Bio's Free Validation Service eliminates trial-and-error by front-loading the proof. Labs can even submit up to 100 biomarkers at once, making it ideal for screening large panels.
'We're not just providing reagents,' Xia adds. 'We're changing expectations. In five years, people will look back and wonder how they ever ordered antibodies without seeing validation data first. This is the new normal.'
Try It Now
Interested researchers can submit their validation requests visit: https://www.bosterbio.com/promotions/free-validation-for-picoband-antibodies
Precision, On Demand: Custom Monoclonal Antibodies Designed for Your Research
In addition to its free validation service, Boster Bio offers custom monoclonal antibody production —a fast, tailored solution for researchers who need highly specific, high-affinity antibodies built from the ground up.
Leveraging decades of expertise in immunogen design and hybridoma technology, Boster Bio guides researchers through every step: from antigen design and immunization to hybridoma screening and large-scale production.
'We design each antigen strategically—accounting for homology, post-translational modifications, epitope localization, and protein structure—so you get antibodies that hit exactly where you need them,' said CJ Xia.
With turnaround times as short as eight weeks, the process balances speed with scientific rigor. Each batch undergoes strict quality controls, including titer testing and cross-reactivity screening, ensuring performance you can trust in assays like WB, IHC, IF, ICC, ELISA, and Flow Cytometry.
Researchers can choose from a growing inventory of over 8,000 antibodies and 500 sample types (including human, mouse, rat, monkey, and zebrafish), or start completely from scratch.
By combining free validation with custom development, Boster Bio now delivers a true end-to-end antibody solution—positioning itself as a single, reliable partner for labs aiming to publish faster, waste less, and innovate more.
About the Company:
Boster Bio is a leading manufacturer of antibodies and ELISA kits critical to advancing life science research. Specializing in custom monoclonal antibody production services and offering free antibody validation, the company supports researchers with high-quality reagents and exceptional service. Based in Pleasanton, CA, Boster Bio continues to innovate in antibody development and immunoassay solutions.
Media Contact
Company Name: Boster Biological Technology
Contact Person: CJ Xia
Email: Send Email
Phone: (888) 466-3604
Address: 3942 Valley Ave
City: Pleasanton
State: CA 94566
Country: United States
Website: https://www.bosterbio.com/
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
30 minutes ago
- CTV News
CTV National News: The trouble of finding a family doctor in Canada
Watch About eight per cent of Canadians over the age of 65 don't have access to a primary care provider. Scott Hurst on the reasons behind the struggle.
Globe and Mail
2 hours ago
- Globe and Mail
Buy Micron Technology (MU) Stock for AI Growth After Record Quarterly Sales?
Reporting strong results for its fiscal third quarter on Wednesday evening, Micron Technology MU is at the top of an expansive list of companies that are experiencing AI-driven growth thanks to high demand for semiconductor memory solutions. Along with other major players in the semiconductor and memory chip space, such as Marvell Technology MRVL and Qualcomm QCOM, Micron is benefiting from the growing demand for high-performance computing components for AI, data centers, and mobile devices. Micron's Record Quarterly Sales Seeing sales of AI-related products more than double, Micron's Q3 sales came in at a quarterly record $9.3 billion. This was a 37% increase from Q3 sales of $6.81 billion in the comparative quarter and comfortably exceeded estimates of $8.83 billion by 5.27%. Micron's high-bandwidth memory (HBM) business stood out, with sales of $1.5 billion marking nearly 50% sequential growth, fueled by demand for AI computing applications. HBM sales helped drive record DRAM (Dynamic Random-Access Memory) revenue of $7.1 billion, as Data Center-specific revenue more than doubled from the surge in memory demand for AI workloads. Micron's Q3 EPS & Other Quarterly Highlights On the bottom line, Micron's Q3 earnings skyrocketed 208% to $1.91 per share ($2.18 billion) from EPS of $0.62 a year ago and crushed expectations of $1.59 a share by 20%. Improved pricing and product mix were the main drivers, with Micron vanquishing a 39% gross margin, compared to 28% in the prior year quarter. Other noteworthy highlights included a six-year peak in free cash flow at $1.95 billion. Micron's Positive Guidance Supported by AI momentum, Micron CEO Sanjay Mehrotra stated the company is on track to deliver record revenue for the full fiscal year. Notably, Micron expects Q4 sales to be $10.7 billion (+/-$300 million), which came in above the current Zacks Consensus of $9.9 billion. Even better, Micron's forecast for Q4 EPS of $2.50 (+/- 15 cents) was well above expectations of $2.02. Bottom Line There was a lot to like about Micron's strong Q3 results, and there could very well be more upside for MU shares, which are up nearly +50% this year. However, following such an extensive year-to-date rally, Micron stock currently lands a Zacks Rank #3 (Hold). To that point, more upside will largely depend on what will hopefully be a positive trend of earnings estimate revisions (EPS) in the coming weeks, given Micron's AI growth and reassuring guidance. Research Chief Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months. Free: See Our Top Stock And 4 Runners Up Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Micron Technology, Inc. (MU): Free Stock Analysis Report QUALCOMM Incorporated (QCOM): Free Stock Analysis Report Marvell Technology, Inc. (MRVL): Free Stock Analysis Report
Globe and Mail
2 hours ago
- Globe and Mail
First Nations express concern about Alberta's data-centre strategy in open letter to province
A group of First Nations communities in Alberta is criticizing the province's electrical grid operator for how it will allot scarce power to proposed data centres, saying the approach undermines the goal of attracting the large facilities necessary for artificial-intelligence applications. Four First Nations chiefs wrote an open letter to Premier Danielle Smith and other government members on Thursday arguing the methodology used by the Alberta Electric System Operator (AESO) 'risks pitting smaller entities against each other for an insufficient share' of electricity. 'Alberta's current framework is capping our potential at the very moment we should be unleashing it,' the letter states. The letter was signed by the chiefs of Enoch Cree Nation, Alexis Nakota Sioux Nation, Alexander First Nation and Paul First Nation. Some proposed data centres in the province are located on the First Nations' territory. 'We're not on the sidelines. We are ready to invest and to help build,' said Chief Tony Alexis of Alexis Nakota Sioux Nation in an interview. In December, the provincial government launched an AI data-centre strategy to entice companies to build in Alberta, emphasizing its abundant natural gas resources for power generation. Alberta wants to attract massive data centres to power generative AI. But current infrastructure can't handle their near-endless demand for electricity The sales pitch may have worked too well. There are 29 projects requesting to be connected to more than 16,000 megawatts of electricity, which exceeds the peak consumption in Alberta. AESO said earlier this month it had identified 15 projects for consideration to connect to the grid, and that qualifying developers will receive a pro rata share of a total of 1,200 megawatts through to 2028. To qualify, developers have to show proof of financial security and letters of support from communities in which they intend to operate. 'The current policy slices new power capacity into portions too small for global tech giants,' Mr. Alexis said. Companies such as Microsoft MSFT-Q, Amazon AMZN-Q and Meta Platforms META-Q are among the biggest developers of AI, and require energy-hungry data centres to build and run the technology. By spreading out electricity among too many projects, the First Nations chiefs contend that Alberta may not be able to attract these companies. Canada's first AI Minister Evan Solomon on his plan to scale up the industry Paul Poscente, chief executive of Axxcelus Capital Advisory and investment adviser to Alexis Nakota Sioux Nation, said that AESO should rethink how it distributes electricity to allow for larger projects in the near-term. 'You need these big anchor tenants, at least one or two of them,' he said. 'We can provide for a bunch of these small guys in Phase 2.' The Premier's office referred a request for comment to the Minister of Affordability and Utilities. 'The short-term 1,200 megawatt limit is not a cap. It will enable data centre projects in advanced stages of planning and development to get started, while government works to develop a long-term framework,' wrote spokesperson Ashli Barrett in an e-mail, adding the government supports AESO's approach. Aaron Engen, the chief executive of AESO, said that even the large U.S. tech companies do not require massive amounts of electricity from the start. 'This concept that you've got to have 1,000 megawatts out of the gate or you've got nothing, it's not true,' he said. Companies can scale up over time, such as by building their own power generation or striking an agreement with an electricity producer. Mr. Engen said he had to keep the process fair as well. 'We as Albertans should be a little uncomfortable when the AESO or anybody in a position like us tries to pick winners and losers,' he said. AESO had to consider grid reliability and the potential cost of system upgrades to accommodate large electrical loads when devising its allotment strategy, Mr. Engen said, adding that it's looking at the next phase of development. 'It's about finding ways to facilitate everybody.' Capital Power LP CPX-T, which operates power generation assets in Canada and the U.S., made the same criticism as the First Nations chiefs earlier this month. The Edmonton-based company has a proposed data-centre campus for up to 1,500 megawatts, but could receive less than 250 megawatts under AESO's methodology. The provincial government, however, has been clear that its preference is for data-centre operators to supply their own power generation, so as not to overload the grid and ensure electricity prices remain stable. But some companies have argued that building new generation assets will take years, and there is a global race to build data centres for AI.
